LifeMD (LFMD) Shares Outstanding (Diluted Average) (2014 - 2026)

LifeMD has reported Shares Outstanding (Diluted Average) for 13 years, with the latest figure at $47.3 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 9.74% year-over-year to $47.3 million; the trailing twelve-month figure through Mar 2026 stood at $47.3 million (up 9.74% YoY), and the FY2025 full-year result was $45.1 million, up 9.55% from the prior year.
• Shares Outstanding (Diluted Average) for Q1 2026 stood at $47.3 million, up from $45.1 million in the prior quarter.
• The five-year high for Shares Outstanding (Diluted Average) was $47.3 million in Q1 2026, with the low at $30.8 million in Q2 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $37.7 million across 5 years, with a median of $39.2 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) rose 26.1% — and 2023, when it gained 2.68%.
• LifeMD's Shares Outstanding (Diluted Average) stood at $31.0 million in 2022, then gained by 9.45% to $33.9 million in 2023, then increased by 21.5% to $41.2 million in 2024, then gained by 9.55% to $45.1 million in 2025, then increased by 4.89% to $47.3 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $47.3 million (Q1 2026), $45.1 million (Q4 2025), and $44.6 million (Q3 2025), per Business Quant data.